Guidelines on the Diagnosis and Treatment of Pulmonary Hypertension: Summary of Recommendations-Reference-Cited by-同舟云学术

Guidelines on the Diagnosis and Treatment of Pulmonary Hypertension: Summary of Recommendations

Published:2018-04 Issue:4 Volume:54 Page:205-215
ISSN:1579-2129
Container-title:Archivos de Bronconeumología (English Edition)
language:en
Short-container-title:Archivos de Bronconeumología (English Edition)

Author:

Barberà Joan Albert,Román Antonio,Gómez-Sánchez Miguel Ángel,Blanco Isabel,Otero Remedios,López-Reyes Raquel,Otero Isabel,Pérez-Peñate Gregorio,Sala Ernest,Escribano Pilar

Publisher

Elsevier BV

Reference46 articles.

1. Diagnóstico y tratamiento de la hipertensión pulmonar;Barberà,2017

2. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension

3. Study of the BMPR2 gene in patients with pulmonary arterial hypertension;Portillo;Arch Bronconeumol,2010

4. Novel mutations in BMPR2, ACVRL1 and KCNA5 genes and hemodynamic parameters in patients with pulmonary arterial hypertension;Pousada;PLOS ONE,2014

5. A founder EIF2AK4 mutation causes an aggressive form of pulmonary arterial hypertension in Iberian Gypsies;Tenorio;Clin Genet,2015

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Echocardiographic assessment of left ventricular myocardial strain, as a non-invasive method for diagnosing pulmonary hypertension in patients with end-stage chronic kidney disease;Transplantologiya. The Russian Journal of Transplantation;2023-12-19

2. Fatty Oil of Descurainia Sophia Nanoparticles Improve Monocrotaline-Induced Pulmonary Hypertension in Rats Through PLC/IP3R/Ca2+ Signaling Pathway;International Journal of Nanomedicine;2023-12

3. The Mechanism of Triacetyl Andrographolide in Inhibiting Proliferation of Pulmonary Artery Smooth Muscle Cells;International Journal of Drug Discovery and Pharmacology;2023-09-28

4. The percentage of circulating fibrocytes is associated with increased morbidity of pulmonary hypertension in patients on hemodialysis;Seminars in Dialysis;2023-01-24

5. Use of Oral Anticoagulant Drugs in Patients with Pulmonary Hypertension;Heart Failure Clinics;2023-01